Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Aim: The aim of this study is to investigate if Preimplantation Genetic Testing (PGT) can effectively identify unreported variants according to American College of Medical Genetics and Genomics (ACMG)to prevent citrullinemia type 1 affection.
Design: This study involves a detailed case analysis of a family with history of citrullinemia type 1, focusing on the use of PGT for monogenic diseases (PGT-M). The genetic variants were identified using ACMG guidelines, and PGT was employed to prevent the inheritance of these variants. The study included haplotype analysis and Sanger sequencing to confirm the results.
Results: The study identified previously unreported variations in the ASS1 gene causing citrullinemia type 1. PGT successfully prevented the transmission of these variants, resulting in the birth of a healthy fetus. However, challenges such as allele dropout (ADO) and gene recombination were encountered during haplotype analysis, which could potentially defeat the diagnosis. The study demonstrated that combining haplotype analysis with Sanger sequencing can enhance the accuracy of PGT.
Conclusion: Preimplantation Genetic Testing (PGT) targeting likely pathogenic and pathogenic variants in the ASS1 gene, as rated by ACMG, allows the birth of healthy infants free from citrullinemia type 1. Additionally, the establishment of single haplotypes and Sanger sequencing can reduce the misdiagnosis rate caused by allele dropout (ADO) and genetic recombination.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11338862 | PMC |
| http://dx.doi.org/10.3389/fgene.2024.1389461 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case Report: From coma to genetic insights: identification of a novel pathogenic variant in Chinese neonatal CTLN1.
Front Pediatr
August 2025
Department of Neonatology, Shenzhen Third People's Hospital (The Second Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.
Citrullinemia type I (CTLN1) is an autosomal recessive disorder caused by variants in the arginine succinate synthase gene (). These variants result in arginine succinate synthase deficiency, leading to a disruption of the urea cycle and hyperammonemia. To date, only a handful of CTLN1 cases have been reported in China.
View Article and Find Full Text PDFDeep phenotyping of patients with citrin deficiency in Singapore- single centre experience.
Mol Genet Metab
July 2025
Genetics Service, Department of Paediatrics, KK Women's and Children's Hospital, Singapore; SingHealth Duke-NUS Genomic Medicine Centre, Singapore. Electronic address:
Background: Citrin deficiency (CD) is a pan-ethnic autosomal recessive inborn error of metabolism due to-pathogenic variants in the SLC25A13 gene which results in disruptions of multiple metabolic pathways including glycolysis, gluconeogenesis, lipogenesis, the urea cycle, and tricarboxylic cycle.
Methods: A retrospective observational study of CD patients managed according to standard clinical practice at a single centre in Singapore (KK Women's and Children's Hospital, KKH) was undertaken from August 2016-August 2024. We present the largest cohort of patients reported in Southeast Asia focusing on clinical, biochemical and imaging findings at diagnosis, and long-term outcomes/management (including drug therapy, food preferences/adherence, hospital admissions, growth, neurodevelopmental, biochemical, and imaging outcomes).
99 Chinese ASS1 carriers: Genetics, metabolism, and citrulline levels.
Clin Chim Acta
July 2025
Department of Genetics and Metabolism, Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng Road, Binjiang District, Hangzhou, Zhejiang, China. Electronic address:
Citrullinemia type I is an autosomal recessive disorder caused by mutations in the ASS1 gene, whereas ASS1 mutation carriers typically have a mutation in only one allele. While carriers are usually asymptomatic, they often show mildly elevated plasma citrulline levels. This study aims to investigate the relationship between the genetic background of ASS1 carriers and plasma citrulline levels, as well as the potential mechanisms behind the elevation.
View Article and Find Full Text PDFNeonatal-onset citrin deficiency: long-term outcomes in four cases and identification of a novel variant.
Turk J Pediatr
July 2025
Department of Rare Diseases, Institute of Graduate Studies in Health Sciences, İstanbul University, İstanbul, Türkiye.
Background: Citrin deficiency (CD), caused by mutations in the SLC25A13 gene, is a rare autosomal recessive urea cycle disorder with variable clinical presentations depending on age. These include neonatal intrahepatic cholestasis (NICCD), failure to thrive with dyslipidemia, and adult-onset type II citrullinemia. Patients with NICCD typically present with transient intrahepatic cholestasis in infancy, which often resolves spontaneously by one year of age; however, some may progress to severe complications later in life.
View Article and Find Full Text PDFNeonatal intrahepatic cholestasis caused by citrin deficiency: clinical features, genetic characteristics, and treatment outcomes.
BMC Gastroenterol
July 2025
International Medical Center, Endoscopy Center and Gastroenterology Department, Shenzhen Children's Hospital, Shenzhen, Guangdong, 518036, China.
Background: Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) is an autosomal recessive disorder with heterogeneous clinical manifestations. This study aimed to characterize the clinical, biochemical, and genetic spectrum of NICCD and evaluate treatment outcomes.
Methods: This retrospective cohort study analyzed molecularly confirmed cases of NICCD admitted to Shenzhen Children's Hospital between March 2019 and April 2023.